Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
about
Cancer treatment-related cardiac toxicity: prevention, assessment and management.EXercise to prevent AnthrCycline-based Cardio-Toxicity (EXACT) in individuals with breast or hematological cancers: a feasibility study protocolCardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts.Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study.Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy.Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress.ACT-ONE - ACTION at last on cancer cachexia by adapting a novel action beta-blocker.The Positive Effects of Exercise in Chemotherapy-Related Cardiomyopathy.Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study.Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia.Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience.Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), SpanBreakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Rehabilitation of Cancer Survivors with Long-Term Toxicities.Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity.MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β-catenin and Wnt signaling.Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy.Lung cancer as a cardiotoxic state: a review.Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.Chemotherapy-induced cardiotoxicity: importance of early detection.Cardiovascular disease and physical activity in adult cancer survivors: a nested, retrospective study from the Atlantic PATH cohort.Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy.Beneficial role of virgin coconut oil supplementation against acute methotrexate chemotherapy-induced oxidative toxicity and inflammation in ratsBioinformatics identification of potential candidate blood indicators for doxorubicin-induced heart failure
P2860
Q30276456-72ED030B-13F8-414B-916A-9A327842EC5BQ37497677-F41A5462-6F4E-41B3-9E5B-63E0F080B303Q38657849-02D54A3E-82D5-4791-A98B-40AA5ECAB841Q38858796-AB3014DF-1153-4F51-BEED-0E0313389566Q39018351-DFCDFFA0-1198-4956-B8F1-7D33F88B2DC0Q42368225-C75C8FCE-A78F-46D2-BA88-C2C8A09DB775Q42398016-AEBE16B6-17FE-4334-9AD4-2735BC61F001Q46269647-0B760015-FEE2-435E-9AE8-E36213EE4B4EQ47146166-6338CF99-9C66-4D2E-BFF4-1FDD00EA8881Q47253203-B6B7F224-7008-463E-8D74-68D55CE8E1D7Q47576767-4D32805C-86F7-41D1-93A1-47AF7880E024Q47579480-6B4A9A73-C657-44FB-A8FC-6F5E6B609514Q49315568-EB51564C-5219-4547-BA06-88D24C6AF4EBQ49572401-0A0AB14C-D75D-4539-A279-E170415D631FQ49706717-E3496526-7303-4D5C-BF01-3D81EFFBAE40Q51742707-0FAE458B-2367-4FD2-811B-0695473C832EQ52577546-A89717BA-295A-4C57-BFEB-6FEC318D10E6Q53117997-E7AC7B2D-AC2B-473C-BFFA-7FD170CD2CA6Q53292554-DFD0EFD3-C688-49AE-93BD-3075190308B7Q53748861-AA1B09D2-2DC7-478F-996B-76C27B455E65Q54456824-CC7666F8-F70D-43B4-929A-DEAE71DC7CE9Q54959206-7C075CBD-9197-420B-9774-33D055458310Q54976923-F6FA7F9A-D6F7-4197-9263-08DCDD8AD4B6Q57124510-D4A91C65-DE6B-450D-9588-6BBFE4DDC1A4Q57163637-59B93675-4537-41C3-8485-E224D3A55FFB
P2860
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
@ast
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
@en
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
@nl
type
label
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
@ast
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
@en
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
@nl
prefLabel
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
@ast
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
@en
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
@nl
P2093
P3181
P356
P1433
P1476
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
@en
P2093
Carlo Maria Cipolla
Carmen Criscitiello
Daniel Lenihan
Olexiy Aseyev
Susan Dent
P304
P3181
P356
10.3322/CAAC.21341
P407
P577
2016-07-01T00:00:00Z